Linked Life Data

19751186

Source:http://linkedlifedata.com/resource/pubmed/id/19751186

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-1-4
pubmed:abstractText
Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver damage and alteration of hepatic enzymes. NAFLD is strongly associated with metabolic syndrome and obesity. It is characterized by fat accumulation in the liver that may progress throughout hepatic steatosis and inflammation (non-alcoholic steatohepatitis [NASH]) toward cirrhosis and liver failure. In the last decade several studies suggested that NAFLD is an independent cardiovascular risk factor that increases cardiovascular mortality. At present, several studies investigating possible therapeutic approaches are ongoing. The present review is focused on the current and promising treatments of NAFLD.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1871-529X
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
261-70
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Update on the treatments of non-alcoholic fatty liver disease (NAFLD).
pubmed:affiliation
Clinic of Internal Medicine I, Department of Internal Medicine, University of Genoa, Genoa, Italy.
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't